Skip to main content
. 2017 Mar 15;2017(3):CD012600. doi: 10.1002/14651858.CD012600

Barrett 2008.

Clinical features and settings Routine screening
Participants 10,273 participants with complete screening and outcome data
Australia ‐ screening programme, independent ultrasound practices
24‐month period (dates not specified)
Pregnant women
Mean maternal age 34.9 years (screen positive) and 30.5 years (screen negative)
Singleton pregnancies
11‐13 weeks' gestation
Study design Cohort study
Target condition and reference standard(s) Down's syndrome: 32 cases
Reference standard: karyotyping or follow‐up to birth
Index and comparator tests NT (FMF protocol)
First trimester PAPP‐A and free ßhCG (90.2% by time resolved amplified cryptate emission technology, Kryptor random access immunoassay analyzer, Brahms, 9.8% by manual Ortho Clinical Diagnostic Immunometric I125 immunoassay for PAPP‐A, and Ortho Clinical Diagnostics Vitros ECi automated analyzer for ßhCG)
Risk cut‐off 1:300
Follow‐up Linkage to data collected by the Midwives Notification System and the Western Australia Birth Defects Registry and by searching laboratory records of all prenatal cytogenetics services in the state.
162 women lost to follow‐up were excluded
Pregnancy loss in 54 women due to miscarriage (n = 35), stillbirth (n = 17) and neonatal death (n = 2)
Aim of study To investigate associations between combined first‐trimester screen result, pregnancy associated plasma protein level and adverse fetal outcomes in women
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Yes All women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements
Withdrawals explained? 
 All tests No No details of withdrawals given